TWIN FOCUS CAPITAL PARTNERS, LLC

Position in MRNA — Moderna, Inc.

CIK 1387761 Boston, MA

Position in MRNA

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$12,997,638

+$3,569,108 QoQ

Shares Held

185,601

0.0% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

4.58%

of 13F equity value

Holder Rank

#89

of 779 holders

Holding Since

Sep 2021

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TWIN FOCUS CAPITAL PARTNERS, LLC holds $24,101,992 across 3 Biotechnology names. MRNA ranks #1 (53.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc. This page	185,601	$12,997,638
2	CGEM	Cullinan Therapeutics, Inc.	595,489	$10,843,854
3	RNAC	Cartesian Therapeutics, Inc.	25,000	$260,500

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,997,638	185,601	0.0%	Shares	Sole	2026-07-28
2026-03-31	$9,428,530	185,601	+0.1%	Shares	Sole	2026-05-14
2025-12-31	$5,469,805	185,480	+33501.4%	Shares	Sole	2026-02-17
2021-09-30	$212,442	552	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.